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Abstract
Transmission of respiratory syncytial virus (RSV) from children with
lower respiratory tract infection (LRTI) at a paediatric intensive-
care unit (PICU) was examined using a highly sensitive real-time
PCR. Twenty-four children with RSV LRTI were admitted during
the study period (total days of potential transmission: 239). Forty-
eight RSV-negative patients were followed up for RSV acquisition
every 5 days (total days of exposure: 683). No single RSV transmis-
sion was documented with this highly sensitive diagnostic method.
Therefore, routine infection control measures of LRTI patients
seem to be adequate to prevent RSV transmission at the PICU.
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Community-acquired respiratory syncytial virus (RSV) lower
respiratory tract infection (LRTI) is a common reason for
admission to a paediatric intensive-care unit (PICU) [1–3].
RSV has been shown to be transmitted to other patients,
causing nosocomial infections with significant morbidity [4].
Research on the frequency of transmission of RSV at the
PICU has shown contradictory results [5–8]. RSV detection
has traditionally been performed with direct immunofluores-
cence (DIF) and viral culture. Real-time PCR is a more sensi-
tive detection method than DIF and viral culture [9], but is
also more expensive. This is the first study using real-time
PCR to prospectively reveal RSV transmission from children
with RSV LRTI to other children admitted to a PICU. To
confirm that RSV acquisition was nosocomial, patients were
assessed for asymptomatic carriage of RSV upon admission
to the PICU, and subsequently every 5 days.
During the RSV season of 2005–2006, 24 patients with
RSV LRTI were admitted to the PICU of Wilhelmina Chil-
dren’s Hospital. Every 5 days, it was determined whether
patients were still shedding virus. If a patient with RSV LRTI
was admitted to the unit, other patients without LRTI who
were present in the unit or admitted to the unit were tested
for RSV. This surveillance was continued during all periods in
which patients were shedding RSV (‘RSV-positive periods’).
Exclusion criteria were as follows: (i) post-head trauma sta-
tus; (ii) discomfort of sampling was deemed to be unethical;
and (iii) PICU stay <12 h/weekend only. As RSV surveillance
of non-LRTI patients was part of routine infection control
measures; according to the Medical Ethical Research Council
of the institution, there was no need for patient consent/
ethical approval. Every child without LRTI who stayed at
the PICU for >3 days was eligible for follow-up. For logistic
reasons, all children at the unit were sampled on the same
day (‘sample day’), every 5 days.
RSV detection was performed by examining nasopharyn-
geal aspirates in intubated children and throat swabs in extu-
bated children. Specimens were examined with DIF, viral
culture and real-time PCR as previously described [9–11]. In
short, part of the sample was inoculated onto HEp cells for
viral culture, and examined twice weekly for cytopathogenic
effect. A second aliquot was used for DIF detection (Imagen;
DaKo, Glostrup, Denmark). DIF was not performed on
throat swabs. The last part of the sample was used for real-
time PCR [9–11]. Briefly, after nucleic acid extraction
(MagNA pure LC; Roche Diagnostics, Basel, Switzerland),
cDNA was synthesized using MultiScribe reverse transcrip-
tase and random hexamers (both from Applied Biosystems,
Foster City, CA, USA). Finally, amplification was carried out
in duplicate in a 25-lL reaction mixture. Murine encephalo-
myocarditis virus was used as an internal control virus to
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monitor for efficient extraction, cDNA synthesis, and amplifi-
cation [12]. As transmission of RSV occurs mainly through
contact with objects rather than through aerosols, routine
infection control measures for LRTI patients included rigor-
ous hand hygiene, together with gloving and gowning.
During the study period, 24 RSV LRTI patients were admit-
ted, staying for a mean of 10 days (standard deviation: 4.4 days).
Follow-up samples remained positive for a mean of 7 days
(standard deviation: 4.8 days). In total, RSV LRTI patients were
shedding virus for 239 days. During the RSV-positive periods,
87 children were tested for RSV upon admission (Fig. 1; 58
nasopharyngeal aspirates and 29 throat swabs).
Seven of the 87 examined patients were found to be
asymptomatic carriers of RSV (four identified by PCR and
DIF, and three identified by PCR only). Age and length of
stay were diverse among these patients. Most children had a
significant medical history, and were admitted for surgical
reasons. Notably, two children had suffered from an RSV
infection 1 week prior to admission to the PICU. However,
none of these patients showed any sign of LRTI during their
entire stay at the PICU.
Fifty-eight patients stayed at the PICU for >3 days. Forty-
eight patients (83%) stayed long enough to be present during
at least one ‘sample day’, and follow-up results were there-
fore available. In total, non-LRTI patients were exposed for
683 days to RSV-shedding LRTI patients. None of the
patients was found to acquire RSV during follow-up, regard-
less of whether real-time PCR, viral culture or DIF tests
were analysed.
For the detection of RSV, real-time PCR was the viral test
with the highest positivity rate. With real-time PCR, 31 RSV-
positive patients were detected, whereas viral culture and
DIF revealed 13 and 21 RSV-positive patients, respectively.
Several limitations of our study warrant further discussion.
First, it was not possible to sample all eligible PICU patients
to determine asymptomatic carriership, owing to early dis-
charge, absence from the unit for additional tests or surgery,
or technical problems. Second, owing to the study design, in
which the entire PICU population was sampled on the same
day (‘sample day’), every 5 days, there was no follow-up
sample for some patients who stayed for >3 days at the
PICU. Third, RSV transmission was assessed only when
patients with RSV LRTI were admitted to the PICU.
An unexpected finding of the study was that seven
patients without LRTI were found to carry RSV upon admis-
sion. These asymptomatic RSV patients can shed RSV and
cause nosocomial infections, especially because they are not
recognized and no infection control measures are taken. RSV
is believed to be shed for up to 2 weeks after symptoms
occur; however, most of the literature on RSV shedding is
based on viral culture results and not on more sensitive tests
such as real-time PCR [13]. Thus, the length of time for
which RSV patients shed RSV is not obvious. Therefore, the
impact of asymptomatic shedders at the PICU must be the
focus of further study, and these studies must maintain RSV
surveillance during periods in which the PICU seems to be
‘RSV-free’.
In conclusion, children with RSV LRTI admitted to the
PICU during the RSV season were not found to transmit
RSV to patients without LRTI, even though a highly sensitive
real-time PCR assay was used. Therefore, routine infection
control measures for LRTI patients seem to be adequate to
prevent RSV transmission at the PICU.
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Abstract
A novel parvovirus, human bocavirus (HBoV), was first discov-
ered in children with respiratory tract infections in Sweden.
A retrospective study of HBoV in faecal samples from children
suffering from diarrhea, covering a 3-year period (November
2000 to October 2003) in Wuhan, China, was undertaken. PCR
assays were used to evaluate 214 faecal samples and to deter-
mine the role of HBoV in diarrhoea. Among 196 virus-infected
children with diarrhoea, 2.55% were HBoV-positive; however, all
HBoV-positive patients were co-infected with common enteric
viruses. This result does not support the notion that HBoV is a
viral agent causing acute diarrhoea.
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In 2005, Allander et al.[1]described a previously uncharacter-
ized virus in nasopharyngeal aspirates from children suffering
from respiratory tract diseases, and provisionally named it
human bocavirus (HBoV). Its global prevalence in respiratory
samples from children, infants and rarely, adults with various
respiratory diseases has been reported to be 3–19% [1–10].
Several studies have reported detection of HBoV in 0.8–9.1%
of faecal samples from children with diarrhoea [8,11–13].
This newly identified virus has therefore been described as
an enteric pathogen, and also a respiratory pathogen
[3,4,10,14–16]. To elucidate the possible clinical role of
HBoV infection, we retrospectively investigated faecal sam-
ples from children with diarrhoea in Wuhan, China, for the
presence of the virus using PCR techniques. In this pilot
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